story of the week
Updated Overall Survival of Ribociclib Plus Endocrine Therapy vs Endocrine Therapy Alone in Pre- and Perimenopausal Patients With HR+/HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Updated Overall Survival of Ribociclib Plus Endocrine Therapy vs Endocrine Therapy Alone in Pre- and Perimenopausal Patients With HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Clin. Cancer Res 2021 Dec 29;[EPub Ahead of Print], YS Lu, SA Im, M Colleoni, F Franke, A Bardia, F Cardoso, N Harbeck, S Hurvitz, L Chow, J Sohn, KS Lee, S Campos-Gomez, R Villanueva Vazquez, KH Jung, KG Babu, P Wheatley-Price, M De Laurentiis, YH Im, S Kuemmel, N El-Saghir, R O'Regan, C Gasch, N Solovieff, C Wang, Y Wang, A Chakravartty, Y Ji, D TripathyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.